EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Full-Thickness Perfused Skin-on-a-Chip with In Vivo-Like Drug Response for Drug and Cosmetics Testing

Stephen Rhee iD, Chunguang Xia, Aditya Chandra, Morgan Hamon iD, Geonhui Lee iD, Chen Yang iD, Zaixun Guo, Bingjie Sun

Bioengineering · 2024-10-23 · 11 (11) · 1055

DOI: 10.3390/bioengineering11111055 ↗

At a glance

Journal article in Bioengineering, published online on 2024-10-23. Written by Stephen Rhee and 7 co-authors. Institution: BMF Biotechnology, Inc., San Diego, CA 92121, USA. Cited 26 times so far (Crossref); 66 references. The full text is freely available (open access, CC BY 4.0). Funded by: BMF Biotechnology, Inc..

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

In this study, we present a novel 3D perfused skin-on-a-chip model fabricated using micro-precision 3D printing, which offers a streamlined and reproducible approach for incorporating perfusion. Perfused skin models are well-regarded for their advantages, such as improved nutrient supply, enhanced barrier function, and prolonged tissue viability. However, current models often require complex setups, such as self-assembled endothelial cells or sacrificial rods, which are prone to variability and time-consuming. Our model uses projection micro-stereolithography 3D printing to create precise microcapillary-like channels using a biocompatible resin, overcoming the drug-absorbing properties of PDMS. A customized chip holder allows for the simultaneous culture of six perfused chips, enabling high-throughput testing. The engineered skin-on-a-chip features distinct dermis and epidermis layers, confirmed via H&E staining and immunostaining. To evaluate drug screening capabilities, inflammation was induced using TNF-α and treated with dexamethasone, with cytokine levels compared to 2D cultures and human skin biopsies. Our 3D model exhibited drug response trends similar to human skin, while showing reduced cytotoxicity over time compared to biopsies. This perfused skin-on-a-chip provides a reliable, physiologically relevant alternative for drug and cosmetics screening, simplifying perfusion setup while preserving key benefits.

Subjects

Author keywords

3D printingdrug screeningorgan-on-a-chipperfusionskinskin-on-a-chip

Authors and institutions

  • BMF Biotechnology, Inc., San Diego, CA 92121, USA.
  • BMF Nano Material Technology Co., Ltd., Shenzhen 518100, China.

ORCID profiles: Stephen Rhee, Morgan Hamon, Geonhui Lee, Chen Yang

Funding

  • BMF Biotechnology, Inc.

Cite

APA

Rhee, S., Xia, C., Chandra, A., Hamon, M., Lee, G., Yang, C., Guo, Z., & Sun, B. (2024). Full-Thickness Perfused Skin-on-a-Chip with In Vivo-Like Drug Response for Drug and Cosmetics Testing. Bioengineering, 11(11), 1055. https://doi.org/10.3390/bioengineering11111055

Vancouver

Rhee S, Xia C, Chandra A, Hamon M, Lee G, Yang C, et al. Full-Thickness Perfused Skin-on-a-Chip with In Vivo-Like Drug Response for Drug and Cosmetics Testing. Bioengineering. 2024;11(11):1055. doi:10.3390/bioengineering11111055

BibTeX
@article{Rhee2024,
  author = {Rhee, Stephen and Xia, Chunguang and Chandra, Aditya and Hamon, Morgan and Lee, Geonhui and Yang, Chen and Guo, Zaixun and Sun, Bingjie},
  title = {Full-Thickness Perfused Skin-on-a-Chip with In Vivo-Like Drug Response for Drug and Cosmetics Testing},
  journal = {Bioengineering},
  year = {2024},
  volume = {11},
  number = {11},
  pages = {1055},
  doi = {10.3390/bioengineering11111055}
}
Start for free →